XML 41 R30.htm IDEA: XBRL DOCUMENT v3.21.2
SHARES-BASED AWARDS (Tables)
12 Months Ended
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of share option activity

A summary of share option activity under the 2009 Plan and the 2014 Plan is as follows:

Outstanding Options

    

Weighted-

Weighted

Average

Average

Remaining

Intrinsic

Shares Available for

Number of

Exercise

Contractual

Value (in

    

Grant

    

Options

    

Price

    

Term

    

thousands)

Balance – January 1, 2019

 

50,917,795

 

38,909,781

 

$

0.40

 

6.37

$

12,341

Options granted

 

(34,221,332)

 

34,221,332

 

0.83

 

 

Options exercised

 

 

(1,123,068)

 

0.46

 

 

Options canceled

 

2,702,200

 

(2,702,200)

 

0.73

 

 

Balance – December 31, 2019

 

19,398,663

 

69,305,845

 

$

0.60

 

6.27

$

21,236

Options granted

 

(23,820,351)

 

23,820,351

 

1.16

 

 

Options exercised

 

 

(7,502,955)

 

0.43

 

 

Options canceled

 

14,947,923

 

(14,947,923)

 

0.44

 

 

Balance – December 31, 2020

 

10,526,235

 

70,675,318

 

0.84

 

7.79

$

118,155

Options vested and exercisable December 31, 2020

 

69,038,732

 

$

0.66

 

6.75

$

75,944

Summary of the assumptions utilized to record compensation expense for share options granted

A summary of the assumptions the Company utilized to record compensation expense for share options granted during the years ended December 31, 2020 and 2019, is as follows:

Year Ended December 31, 

 

    

2020

    

2019

  

Weighted average volatility

 

58.98

%

42.77

%

Expected term (in years)

 

5.9

 

5.5

Risk-free interest rate

 

0.75

%  

2.11

%

Expected dividends

 

 

Summary of employee and nonemployee share-based compensation expense

Total employee and nonemployee share-based compensation expense, including that related to the extended exercise terms for senior management and consultants for the years ended December 31, 2020 and 2019, is classified in the consolidated statements of operations as follows (in thousands):

Year Ended December 31, 

    

2020

    

2019

Cost of revenue

$

213

$

443

Research and development

 

3,724

 

4,770

Selling, general and administrative

 

677

 

2,506

Total

$

4,614

$

7,719

Senior management  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of the assumptions utilized to record compensation expense for share options granted

Following are the assumptions used in the valuation of these options:

For the Year Ended

  

    

December 31, 2019

Volatility

 

47.5

%

Expected terms (in years)

 

10

Risk-free interest rate

 

2.59

%

Expected dividends